Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis.

Journal of Voice（2019）

引用 6|浏览14

暂无评分

摘要

Administration of nonadjuvant HPV type 6 L1 VLPs vaccine to RRP was generally well tolerated and highly immunogenic.

查看译文

关键词

Recurrent respiratory papilloma,HPV vaccine,VLP,Adjuvant therapy,Treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要